Global Infectious Disease Diagnostics Market is segmented on the basis of product, technology, application, end-user, and region. On the basis of products, the market is segmented into instruments and analyzers, consumables (assays and reagents), and software & services. The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. —
Download Free PDF Brochure of Infectious Disease Diagnostics Market Research Report Now Available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=323163 .
The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
The infectious disease diagnostics study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
#Table of Content
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Infectious Disease Diagnostics Market, By Sales Channel
8 Infectious Disease Diagnostics Market, By Type of Application
9 Infectious Disease Diagnostics Market, By Region
10 Competitive Landscape
11 Company Profiles
Infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out.
Click Here for Discount on Infectious Disease Diagnostics Market Report with Company Profiles at https://www.reportsnreports.com/contacts/discount.aspx?name=323163 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
• Orthodontic product manufacturers, vendors, and distributors
• Venture capitalists and other government funding organizations
• Healthcare service providers (including hospitals and dental & orthodontic clinics)
• Research laboratories
• Academic institutes
• Market research and consultancy firms
• Government and independent regulatory authorities
Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.
More Information and Details on “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=323163 .
The infectious disease diagnostics market is segmented into major seven technologies, namely, immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, and other technologies. In 2017, the immunodiagnostics segment accounted for the largest share of the global market.
Break-up profile of primaries:
• By Company Type - Tier 40%, Tier 30%,and Tier 30%
• By Designation - C-level-27%, D-level-18%, and Others-55%
• By Region - North America-50%, Europe-20%, Asia Pacific-20%,and RoW-10%
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market. Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.
Email: Send Email
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Release ID: 496880